Human Serum Albumin Fusion Protein as Therapeutics for Targeting Amyloid Beta in Alzheimer's Diseases. Bang S, Kuen Song J, Shin SW, Hee Lee K, et al. Neurosci Lett 2021 Oct 18:136298. doi: 10.1016/j.neulet.2021.136298.

Read + Share

Amedeo Smart

Independent Medical Education

Bang S, Kuen Song J, Shin SW, Hee Lee K, et al. Human Serum Albumin Fusion Protein as Therapeutics for Targeting Amyloid Beta in Alzheimer's Diseases. Neurosci Lett 2021 Oct 18:136298. doi: 10.1016/j.neulet.2021.136298.
PMID: 34673147